Quadrise (LON:QED) Shares Down 7.3% - Should You Sell?

Key Points

• Quadrise Plc's share price fell by 7.3% on Monday, trading as low as GBX 3.82 ($0.05) before settling at GBX 4.03 ($0.05).
• The company's insider Jason Miles sold over 1 million shares at an average price of GBX 4 on July 24, contributing to a decrease in stock value.
• Quadrise holds a market cap of £80.25 million and reported a significant PE ratio of -2,352.94, indicating potential challenges in profitability.

Quadrise Plc (LON:QED - )'s share price was down 7.3% on Monday . The stock traded as low as GBX 3.82 ($0.05) and last traded at GBX 4.03 ($0.05). Approximately 4,644,726 shares traded hands during mid-day trading, a decline of 24% from the average daily volume of 6,091,294 shares. The stock had previously closed at GBX 4.35 ($0.06).

Quadrise Stock Performance

The company has a 50 day moving average of GBX 3.45 and a two-hundred day moving average of GBX 3.97. The stock has a market cap of £80.25 million, a PE ratio of -2,352.94 and a beta of 1.83.

Insider Buying and Selling

In other Quadrise news, insider Jason Miles sold 1,013,049 shares of the business's stock in a transaction that occurred on Thursday, July 24th. The stock was sold at an average price of GBX 4, for a total transaction of £40,521.96. Company insiders own 4.60% of the company's stock.

About Quadrise

Quadrise is a global innovator and licensor of the disruptive heavy oil and synthetic biofuel technology that produces its proprietary MSAR® and bioMSAR™ fuels. Quadrise employs a team of energy and fuel experts with extensive experience in commercial emulsion fuels, downstream, marine and power utility applications at a global level. Quadrise's shares have been listed on the London Stock Exchange's AIM market since 2006 AIM: QED.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.